{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:38:37Z","timestamp":1792147117731,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1532\/ijh97.05126","type":"journal-article","created":{"date-parts":[[2006,7,28]],"date-time":"2006-07-28T17:27:09Z","timestamp":1154107629000},"page":"70-73","source":"Crossref","is-referenced-by-count":10,"title":["Marked Hepatomegaly Due to AA Type Amyloidosis in a Case with Castleman's Disease"],"prefix":"10.1007","volume":"84","author":[{"given":"Noboru","family":"Yamagata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyunko","family":"Fujio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risen","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Matsumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tanimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiho","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tateki","family":"Shikai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Takezako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyo","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. <i>Cancer<\/i>. 1956;9: 822-830.","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"E00002","unstructured":"Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. <i>Cancer.<\/i> 1972;29:670-683."},{"key":"E00003","unstructured":"McCarty MJ, Vukelja SJ, Banks PM, Weiss RB. Angiofollicular lymph node hyperplasia (Castleman's disease). <i>Cancer Treat Rev.<\/i> 1995;21:291-310."},{"key":"E00004","unstructured":"Herrada J, Cabanillas FF. Multicentric Castleman's disease. <i>Am J Clin Oncol.<\/i> 1995;18:180-183."},{"key":"E00005","unstructured":"Palestro G, Turrini F, Pagano M, Chiusa L. Castleman's disease. <i>Adv Clin Path.<\/i> 1999;3:11-22."},{"key":"E00006","unstructured":"Pilon VA, Gomez LG, Butler JJ. Systemic amyloidosis associated with a benign mesenteric lymphoid mass. <i>Am J Clin Pathol.<\/i> 1982; 78:112-116."},{"key":"E00007","unstructured":"Ordi J, Grau JM, Junque A, Nomdedeu B, Palacin A, Cardesa A. Secondary (AA) amyloidosis associated with Castleman's disease. <i>Am J Clin Pathol.<\/i> 1993;100:394-397."},{"key":"E00008","unstructured":"Tanaka T, Horita M, Shibayama H, et al. Secondary amyloidosis associated with Castleman's disease. <i>Intern Med.<\/i> 1995;34:122-126."},{"key":"E00009","unstructured":"Kazes I, Deray G, Jacobs C. Castleman's disease and renal amyloidosis. <i>Ann Intern Med.<\/i> 1995;122:395-396."},{"key":"E00010","unstructured":"Lomena F, Rusello R, Pons F, et al. Abnormal scintigraphic evolution in AA hepatic amyloidosis. <i>Clin Nucl Med.<\/i> 1988;13:194-196."},{"key":"E00011","unstructured":"Falk RH, Lee VW, Rubinow A, Hood WB, Cohen AS. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. <i>Am J Cardiol.<\/i> 1983;51:826-830."},{"key":"E00012","unstructured":"Altiparmak MR, Pamuk GE, Pamuk ON, Dogusoy G. Secondary amyloidosis in CD: review of the literature and report of a case. <i>Ann Hematol.<\/i> 2002;81:336-339."},{"key":"E00013","unstructured":"Gillmore JD, Lovat LB, Persey MR, et al. Amyloid load and clonical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. <i>Lancet.<\/i> 2001;358:24-29."},{"key":"E00014","unstructured":"Perfetti V, Bellotti V, Maggi A, et al. Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. <i>Am J Hematol.<\/i> 1994;46:189-193."},{"key":"E00015","unstructured":"Lui SL, Chan KW, Li FK, Cheng IK, Chan TM. Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6. <i>Nephron.<\/i> 1998;78:323-327."},{"key":"E00016","unstructured":"Bowne WB, Lewis JJ, Filippa DA, et al. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. <i>Cancer.<\/i> 1999;85:706-717."},{"key":"E00017","unstructured":"Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. <i>Cancer.<\/i> 2001;92:670-676."},{"key":"E00018","unstructured":"Derici U, Arinsoy T, Ataoglu O, et al. Localized Castleman's disease and nephrotic syndrome not responsive to resection plus colchicine therapy. <i>Ann Hematol.<\/i> 2002;81:399-401."},{"key":"E00019","unstructured":"Ikeda S, Chisuwa H, Kawasaki S, et al. Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum. <i>J Clin Pathol.<\/i> 1997;50:965-967."},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Lachmann HJ, Gilbertson JA, Gillmore JD, et al. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease. Q J Med. 2002;95:211-218.","DOI":"10.1093\/qjmed\/95.4.211"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.05126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T09:23:00Z","timestamp":1555752180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.05126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7,1]]}},"alternative-id":["5U7106575067X284"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.05126","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7,1]]}}}